Bruno Pereira Antunes

Bruno Pereira Antunes

Auto-generated profile, based on publicly available information

Bruno Pereira Antunes

Hospital de Clínicas de Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Acta Ortopedica Brasileira
Verified
Journal Article
Open access
PDF file
RBRicardo Becker
Ricardo Becker
CGCarlos Roberto Galia
Carlos Roberto Galia
JPJulie Francine Cerutti Santos Pestilho
Julie Francine Cerutti Santos Pestilho
BABruno Pereira Antunes
Bruno Pereira Antunes
ABAndré Mathias Baptista
André Mathias Baptista
AGAlex Guedes
Alex Guedes
Introduction: Giant cell tumor of bone (GCTB) mainly affects young adults’ long bone epiphyses, threatening bone strength and joint function. Surgery is the primary treatment, although post-surgery recurrence is significant. This study analyzes patient profiles, treatments, and outcomes for GCTB in Brazil. Methods: We retrospectively assessed local recurrence, metastasis, and treatment approaches in 643 GCTB patients across 16 Brazilian centers (1989-2021), considering regional differences. Results: 5.1% (n=33) developed pulmonary metastases, 14.3% (n=92) had pathological fractures, and the local recurrence rate was 18.2% (n=114). Higher rates of pulmonary metastases (12.1%) and advanced tumors (Campanacci III, 88.9%) were noted in lower-income North and Northeast regions. The North also had more pathological fractures (33.3%), extensive resections (61.1%), and amputations (27.8%). These regions faced longer surgical delays (36-39 days) than the South and Southeast (27-33 days). Conclusions: Our findings corroborate international data, underscoring regional disparities in Brazil that may lead to worse outcomes in disadvantaged areas. This highlights the need for improved orthopedic oncology care in Brazil’s economically and structurally challenged regions. Level of Evidence III; Retrospective Cohort.

1 January 2025 in Acta Ortopedica Brasileira
Verified
Journal Article
Open access
PDF file
EREduardo da Silva Rodrigues
Eduardo da Silva Rodrigues
MGMichelle Ghert
Michelle Ghert
BABruno Pereira Antunes
Bruno Pereira Antunes
CGCarlos Roberto Galia
Carlos Roberto Galia
JPJulie Francine Cerutti Santos Pestilho
Julie Francine Cerutti Santos Pestilho
RBRicardo Becker
Ricardo Becker
Objective: To analyze the evolution of patient/tumor characteristics and treatments for GCTB in the knee in Brazil over 30 years and assess changes in local recurrence rates.

21 July 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
RBRicardo Becker
Ricardo Becker
BPBruno Antunes Pereira
Bruno Antunes Pereira
CGCarlos Roberto Galia
Carlos Roberto Galia
OCOtavio Pereira Cadore
Otavio Pereira Cadore
BFBruno Führ
Bruno Führ
AGAlex Guedes
Alex Guedes
The giant cell tumor of bone (GCTB) represents approximately 5% of primary bone tumors, and more than half of cases affect individuals between 20 and 50 years of age. Despite being a benign neoplasm, 3 to 5% of cases may show pulmonary metastases, besides it has high potential for bone destruction at the main site of the lesion, often in the epiphyses of long bones, which may lead to serious functional problems in affected patients. Multidisciplinary treatment of GCTB has been a cause for discussion in the last decade due to the discovery of drugs such as denosumab that prevent tumor progression and may be useful in cases of patients with local recurrences and unresectable tumors. The therapeutic basis of GCTB remains the isolated surgical treatment by intralesional (with adjuvants), marginal or wide resection. Intralesional treatment presents higher rates of recurrence, however it preserves the adjacent joint function and much of the individual bone stock. Resection with wide margins presents lower recurrence rates but has shown worse functional results and frequent complications in bone reconstructions. Current knowledge of GCTB surgical outcomes has been based on major world series - there is a lack of Brazilian epidemiological and surgical data on this specific type of neoplasm, except for a few series of cases. The primary objective of this paper is to identify the epidemiological profile of GCTB; the secondary objectives are to describe the surgical aspects in the main diagnostic centers and treatment of bone tumors, to analyze the clinical and surgical aspects of patients with GCTB of wrist and hand, and to analyze the clinical and surgical aspects of patients with knee GCTB. These findings may help in the maintenance or change of national guidelines for the treatment of GCTB. This study protocol was submitted to ethical assessment under the CAAE (Ethical Appreciation Presentation Certificate) registry No. 94280918.0.0000.5327 (5th version), evaluated through the substantiated opinion No. 4.770.705, and approved by the Institutional Research Ethics Committee on June 12, 2022.

1 January 2025 in Acta Ortopedica Brasileira
Verified
Journal Article
Open access
PDF file
WRWilliam Bernardo Specht Rabuske
William Bernardo Specht Rabuske
MGMichelle Ghert
Michelle Ghert
BABruno Pereira Antunes
Bruno Pereira Antunes
CGCarlos Roberto Galia
Carlos Roberto Galia
JPJulie Francine Cerutti Santos Pestilho
Julie Francine Cerutti Santos Pestilho
RBRicardo Becker
Ricardo Becker
Objectives: To assess patient and tumor characteristics and treatment outcomes, focusing on local recurrence rates based on treatment type.